BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22075622)

  • 21. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia.
    Nagamatsu T; Fujii T; Kusumi M; Zou L; Yamashita T; Osuga Y; Momoeda M; Kozuma S; Taketani Y
    Endocrinology; 2004 Nov; 145(11):4838-45. PubMed ID: 15284201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation, Culture and Identification of Choriocarcinoma Stem-Like Cells from the Human Choriocarcinoma Cell-Line JEG-3.
    Cai J; Peng T; Wang J; Zhang J; Hu H; Tang D; Chu C; Yang T; Liu H
    Cell Physiol Biochem; 2016; 39(4):1421-32. PubMed ID: 27606814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purified vitexin compound 1 suppresses tumor growth and induces cell apoptosis in a mouse model of human choriocarcinoma.
    Tan Z; Zhang Y; Deng J; Zeng G; Zhang Y
    Int J Gynecol Cancer; 2012 Mar; 22(3):360-6. PubMed ID: 22228428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor-specific regulation of angiogenic growth factors and their receptors during recovery from cytotoxic therapy.
    Taylor AP; Osorio L; Craig R; Raleigh JA; Ying Z; Goldenberg DM; Blumenthal RD
    Clin Cancer Res; 2002 Apr; 8(4):1213-22. PubMed ID: 11948135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulation of the angiogenic factors PlGF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization.
    Viglietto G; Romano A; Manzo G; Chiappetta G; Paoletti I; Califano D; Galati MG; Mauriello V; Bruni P; Lago CT; Fusco A; Persico MG
    Oncogene; 1997 Nov; 15(22):2687-98. PubMed ID: 9400995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular regulation of human placental growth factor (PlGF) gene expression in placental villi and trophoblast cells is mediated via the protein kinase a pathway.
    Depoix C; Tee MK; Taylor RN
    Reprod Sci; 2011 Mar; 18(3):219-28. PubMed ID: 21135203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PlGF) associated with malignancy in human thyroid tumors and cell lines.
    Viglietto G; Maglione D; Rambaldi M; Cerutti J; Romano A; Trapasso F; Fedele M; Ippolito P; Chiappetta G; Botti G
    Oncogene; 1995 Oct; 11(8):1569-79. PubMed ID: 7478581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metal transcription factor-1 is involved in hypoxia-dependent regulation of placenta growth factor in trophoblast-derived cells.
    Nishimoto F; Sakata M; Minekawa R; Okamoto Y; Miyake A; Isobe A; Yamamoto T; Takeda T; Ishida E; Sawada K; Morishige K; Kimura T
    Endocrinology; 2009 Apr; 150(4):1801-8. PubMed ID: 19022893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of placenta growth factor, soluble fms-like tyrosine kinase-1, metal-responsive transcription factor-1, heme oxygenase 1 and hypoxia inducible factor-1α mRNAs in pre-eclampsia placenta and the effect of pre-eclampsia sera on their expression of choriocarcinoma cells.
    Maebayashi Asanuma A; Yamamoto T; Azuma H; Kato E; Yamamoto N; Murase T; Chishima F; Suzuki M
    J Obstet Gynaecol Res; 2014 Oct; 40(10):2095-103. PubMed ID: 25132343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered angiogenesis in preeclampsia: evaluation of a new test system for measuring placental growth factor.
    Schmidt M; Dogan C; Birdir C; Callies R; Kuhn U; Gellhaus A; Janetzko A; Kimmig R; Kasimir-Bauer S
    Clin Chem Lab Med; 2007; 45(11):1504-10. PubMed ID: 17970705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistin regulates human choriocarcinoma cell invasive behaviour and endothelial cell angiogenic processes.
    Di Simone N; Di Nicuolo F; Sanguinetti M; Castellani R; D'Asta M; Caforio L; Caruso A
    J Endocrinol; 2006 Jun; 189(3):691-9. PubMed ID: 16731799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.
    Carmeliet P; Moons L; Luttun A; Vincenti V; Compernolle V; De Mol M; Wu Y; Bono F; Devy L; Beck H; Scholz D; Acker T; DiPalma T; Dewerchin M; Noel A; Stalmans I; Barra A; Blacher S; VandenDriessche T; Ponten A; Eriksson U; Plate KH; Foidart JM; Schaper W; Charnock-Jones DS; Hicklin DJ; Herbert JM; Collen D; Persico MG
    Nat Med; 2001 May; 7(5):575-83. PubMed ID: 11329059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Placental growth factor (PlGF)-specific uptake in tumor microenvironment of 89Zr-labeled PlGF antibody RO5323441.
    Oude Munnink TH; Tamas KR; Lub-de Hooge MN; Vedelaar SR; Timmer-Bosscha H; Walenkamp AM; Weidner KM; Herting F; Tessier J; de Vries EG
    J Nucl Med; 2013 Jun; 54(6):929-35. PubMed ID: 23625582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?
    Bdolah Y; Lam C; Rajakumar A; Shivalingappa V; Mutter W; Sachs BP; Lim KH; Bdolah-Abram T; Epstein FH; Karumanchi SA
    Am J Obstet Gynecol; 2008 Apr; 198(4):428.e1-6. PubMed ID: 18191808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulation of placental growth factor by vascular endothelial growth factor via a post-transcriptional mechanism.
    Yao YG; Yang HS; Cao Z; Danielsson J; Duh EJ
    FEBS Lett; 2005 Feb; 579(5):1227-34. PubMed ID: 15710418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antagonism of EG-VEGF Receptors as Targeted Therapy for Choriocarcinoma Progression
    Traboulsi W; Sergent F; Boufettal H; Brouillet S; Slim R; Hoffmann P; Benlahfid M; Zhou QY; Balboni G; Onnis V; Bolze PA; Salomon A; Sauthier P; Mallet F; Aboussaouira T; Feige JJ; Benharouga M; Alfaidy N
    Clin Cancer Res; 2017 Nov; 23(22):7130-7140. PubMed ID: 28899975
    [No Abstract]   [Full Text] [Related]  

  • 37. Suppression of choriocarcinoma invasion and metastasis following blockade of BDNF/TrkB signaling.
    Kawamura K; Kawamura N; Okamoto N; Manabe M
    Cancer Med; 2013 Dec; 2(6):849-61. PubMed ID: 24403258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.
    Luttun A; Tjwa M; Moons L; Wu Y; Angelillo-Scherrer A; Liao F; Nagy JA; Hooper A; Priller J; De Klerck B; Compernolle V; Daci E; Bohlen P; Dewerchin M; Herbert JM; Fava R; Matthys P; Carmeliet G; Collen D; Dvorak HF; Hicklin DJ; Carmeliet P
    Nat Med; 2002 Aug; 8(8):831-40. PubMed ID: 12091877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blockage of VEGF-induced angiogenesis by preventing VEGF secretion.
    Björndahl M; Cao R; Eriksson A; Cao Y
    Circ Res; 2004 Jun; 94(11):1443-50. PubMed ID: 15192038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The placental growth factor as a target against hepatocellular carcinoma in a diethylnitrosamine-induced mouse model.
    Heindryckx F; Coulon S; Terrie E; Casteleyn C; Stassen JM; Geerts A; Libbrecht L; Allemeersch J; Carmeliet P; Colle I; Van Vlierberghe H
    J Hepatol; 2013 Feb; 58(2):319-28. PubMed ID: 23046674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.